Express Pharma
Home  »  Latest Updates  »  Sun Pharma recalls 3.8 lakh cartons of osteoporosis drug in US

Sun Pharma recalls 3.8 lakh cartons of osteoporosis drug in US


The drug has some presence of ‘unknown impurity’, which was manufactured at the company’s Halol facility in Gujarat

Around 3.8 lakh cartons of an osteoporosis drug manufactured by Sun Pharmaceutical Industries are being recalled in the US and Puerto Rico due to presence of ‘unknown impurity’.

The recall of 3,81,120 cartons of Alendronate Sodium tablets has been initiated by Sun Pharma Global Fze, an arm of the Indian pharma major.

The drug is manufactured at Sun Pharma’s Halol facility in Gujarat, United States Food and Drug Administration (US FDA) said in its latest Enforcement Report.

The cartons are being recalled on account of “observed levels of highest unknown impurity exceeding specification limit at the 3 month stability time point,” the report said.

The ongoing recall falls under Class II, which is initiated “in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote,” it said.

Alendronate Sodium tablets are used for treatment of osteoporosis in postmenopausal women.

Comments are closed.